Genome‐Wide CRISPR‐Cas9 Screening Identifies NF‐κB/E2F6 Responsible for EGFRvIII‐Associated Temozolomide Resistance in GlioblastomaKai Huang, Chunsheng Kang, Qixue Wang et al.|Advanced Science|2019Cited by 106